Revisión sistemática

Published on 15 de julio de 2020 | http://doi.org/10.5867/medwave.2020.06.7966

Lopinavir/ritonavir for COVID-19: A living systematic review

Back to article Figure 6.

Relative risk of serious adverse events for lopinavir/ritonavir versus standard care.